Monoclonal or polyclonal antibodies are extensively used as diagnostic agent, in therapeutic or R&D; however, there is an increasing demand for novel, high-quality antibodies.
Adjuvatis offers a new class of adjuvant for the production of polyclonal / monoclonal antibodies with high affinity. Based on an eco-friendly process of synthesis, the i-Particles® are entirely degradable by natural pathway of the animal body. Lastly, this technology offers a Lego approach, which will permit to optimize the design of multivalent vaccine.
Benfits of formulations based on i-Particles technology
• High safety profile
• Customized formulations
• No degradation of the antigenic properties during the process of formulation
• Improves antigen stability
• Suitable for “difficult” antigens
• Proteins and glycoproteins
• Sensitive polypeptidic molecules
• Synthetic peptides and small peptides
• Reduced toxicity of toxins (Integrin, snake toxins, etc.)
• Haptens, sugars, allergens (ongoing)
• High reproducibility
Adjuvatis provides its customers with ready-to-use formulations in a suitable buffer.
Intense systemic humoral immune response after 3 sub-cutaneous injections with 10 µg of p24 protein from HIV formulated with i-Particles Classic, Advanced or with Alum
R&D – Pharmaceutical development services
10-years expertise in formulating and analyzing particles
From bench to clinic
Single resource and integrative management to meet your pharmaceutical development needs
Please contact us for further information or to request a quotation